Effect of rifampicin & isoniazid on the steady state pharmacokinetics of moxifloxacin

about

Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB.A Review of Moxifloxacin for the Treatment of Drug-Susceptible Tuberculosis.

P2860

Q38973113-83F27EA3-FF18-41BA-B947-06729FE79C3C Q39456569-3F01F167-171E-476C-B112-761CC4E14AF8

P2860

Effect of rifampicin & isoniazid on the steady state pharmacokinetics of moxifloxacin

Item

http://www.wikidata.org/entity/Q36728692

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Effect of rifampicin & isoniazid on the steady state pharmacokinetics of moxifloxacin

@ast

Effect of rifampicin & isoniazid on the steady state pharmacokinetics of moxifloxacin

@en

type

Item

label

Effect of rifampicin & isoniazid on the steady state pharmacokinetics of moxifloxacin

@ast

Effect of rifampicin & isoniazid on the steady state pharmacokinetics of moxifloxacin

@en

prefLabel

Effect of rifampicin & isoniazid on the steady state pharmacokinetics of moxifloxacin

@ast

Effect of rifampicin & isoniazid on the steady state pharmacokinetics of moxifloxacin

@en

P1476

Effect of rifampicin & isoniazid on the steady state pharmacokinetics of moxifloxacin

@en

P2093

A Geetharani

http://www.w3.org/2001/XMLSchema#string

A K Hemanth Kumar

http://www.w3.org/2001/XMLSchema#string

B Nandhakumar

http://www.w3.org/2001/XMLSchema#string

C B Tharani

http://www.w3.org/2001/XMLSchema#string

Geetha Ramachandran

http://www.w3.org/2001/XMLSchema#string

P Sugirda

http://www.w3.org/2001/XMLSchema#string

R Nandini

http://www.w3.org/2001/XMLSchema#string

R Srinivasan

http://www.w3.org/2001/XMLSchema#string

P2860

Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.

The role of fluoroquinolones in tuberculosis today.

The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.

Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis.

Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis.

Rifampin and rifabutin drug interactions: an update.

Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis.

Pharmacokinetic interactions with rifampicin : clinical relevance.

Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy.

Effects of rifampin and multidrug resistance gene polymorphism on concentrations of moxifloxacin

P304

979-984

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

136

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23391793

http://www.w3.org/2001/XMLSchema#string

P932

3612327

http://www.w3.org/2001/XMLSchema#string

Effect of rifampicin & isoniazid on the steady state pharmacokinetics of moxifloxacin

about

P2860

P2860

Effect of rifampicin & isoniazid on the steady state pharmacokinetics of moxifloxacin

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P407

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P407

P433

P478

P577

P698

P932